CYTOKINETICS INC — Director's Dealing 2022

Nov 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-11-02

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-02	Common Stock	M	9208	$7.96	Acquired	415297	Direct
2022-11-02	Common Stock	S	9208	$42.17	Disposed	406089	Direct
2022-11-02	Common Stock	M	792	$9.65	Acquired	406881	Direct
2022-11-02	Common Stock	S	792	$42.17	Disposed	406089	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-02	Non-Qualified Stock Option (Right to Buy)	$7.96	M	9208	Disposed	2025-02-26	Common Stock (9208)	Direct
2022-11-02	Non-Qualified Stock Option (Right to Buy)	$9.65	M	792	Disposed	2024-02-24	Common Stock (792)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.